Skip to content
10-Q

Quarterly Report

Immunoclin Corp

0001517126-14-000304

← back to feed
Filed
Sep 29, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Sep 26, 2014 27.78M sh
Capex Q2 2015 · Jul 31, 2014 $5.52K
Capex Q2 2015 · Jul 31, 2013 $903
Operating Cash Flow Q2 2015 · Jul 31, 2014 −$378.4K
Operating Cash Flow Q2 2015 · Jul 31, 2013 −$94.23K
Stockholders Equity Q2 2015 · Jul 31, 2014 $18.05M
Stockholders Equity Q2 2015 · Jan 31, 2014 $19.8M
Current Liabilities Q2 2015 · Jul 31, 2014 $1.78M
Current Liabilities Q2 2015 · Jan 31, 2014 $725.47K
Current Assets Q2 2015 · Jul 31, 2014 $133.91K
Current Assets Q2 2015 · Jan 31, 2014 $74.01K
Total Assets Q2 2015 · Jul 31, 2014 $19.82M
Total Assets Q2 2015 · Jan 31, 2014 $20.53M
Sga Expense Q2 2015 · Jul 31, 2014 $114.61K
Sga Expense Q2 2015 · Jul 31, 2014 $195.15K
Sga Expense Q2 2015 · Jul 31, 2013 $12.86K
Sga Expense Q2 2015 · Jul 31, 2013 $48.73K
Rd Expense Q2 2015 · Jul 31, 2014 $24.5K
Rd Expense Q2 2015 · Jul 31, 2014 $32.46K
Rd Expense Q2 2015 · Jul 31, 2013 $20.23K
Rd Expense Q2 2015 · Jul 31, 2013 $25.33K
Net Income Q2 2015 · Jul 31, 2014 −$996.72K
Net Income Q2 2015 · Jul 31, 2014 −$1.79M
Net Income Q2 2015 · Jul 31, 2013 −$217.55K
Net Income Q2 2015 · Jul 31, 2013 −$262.1K
Operating Income Q2 2015 · Jul 31, 2014 −$996.72K
Operating Income Q2 2015 · Jul 31, 2014 −$1.79M
Operating Income Q2 2015 · Jul 31, 2013 −$217.55K
Operating Income Q2 2015 · Jul 31, 2013 −$262.1K